Suchergebnisse - (Subject:"Ritonavir")

PubPharm (305)

1

Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment

enthalten in: Antimicrobial agents and chemotherapy | 2009

von Pérez-Elías, M. | Morellon, M. | Ortega, E. | +9

2

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

enthalten in: BMC infectious diseases | 2009

von Mikl, J. | Sulkowski, M. | Benhamou, Y. | +6

3

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

enthalten in: Drug and alcohol dependence | 2009

von Bruce, R. | Altice, F. | Moody, D. | +8

4

Desensitization to tipranavir caused by toxicodermia

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2009

von Martínez Castro, B. | Ferrando Piqueres, R. | Martínez García, M. | +1

5

Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine)

enthalten in: Current opinion in HIV and AIDS | 2009

von Arribas, J.

6

Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial

enthalten in: HIV medicine | 2009

von Hill, A. | Marcelin, A. | Calvez, V.

7

Study of once-daily versus twice-daily fosamprenavir plus ritonavir administered with abacavir/lamivudine once daily in antiretroviral-naïve HIV-1-infected adult subjects

enthalten in: HIV clinical trials | 2009

von Carosi | Lazzarin | Stellbrink | +9

8

Lack of effect of efavirenz on the pharmacokinetics of tipranavir-ritonavir in healthy volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2009

von la Porte, C. | Sabo, J. | Béïque, L. | +1

9

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV : results of the ANRS 139 TRIO trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2009

von Yazdanpanah, Y. | Fagard, C. | Descamps, D. | +71

10

Differential effects of tipranavir plus ritonavir on atorvastatin or rosuvastatin pharmacokinetics in healthy volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2009

von Pham, P. | la Porte, C. | Lee, L. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]